Retrospective analysis of medical and pharmacy claims for patients diagnosed with schizophrenia or bipolar disorder in 24 state Medicaid programs.
Kimberly Laubmeier, PhD
Advertisement
Articles by Kimberly Laubmeier, PhD
Advertisement
Latest Updated Articles
- Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients With Schizophrenia and Bipolar Disorder in Medicaid
Published: February 24th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
4
Delivering Value-Based Oncology Care in the Age of Biomarker Testing, Targeted Therapies, and Immunotherapies
5
